Kechow Pharma Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 80

Employees
  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 12

Kechow Pharma General Information

Description

Researcher and developer of new anti-cancer drugs. The company focuses on the R&D and production of new anti-cancerous drugs with specialized drug development team from discovery, clinical development to registration, enabling patients providing high-quality oncology drugs to meet clinical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • Block M, Floor 3, No. 780 Cailun Road
  • Zhangjiang Hi-Tech Park, Pudong New Area
  • Shanghai, 201203
  • China
+86 021 0000 0000

Kechow Pharma Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kechow Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 22-Dec-2022 00000 Completed Clinical Trials - Phase 2
6. Secondary Transaction - Private 17-Sep-2020 00000 Completed Clinical Trials - Phase 2
5. Later Stage VC (Series D) 23-May-2019 000.00 00000 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series C) 24-Oct-2019 000.00 0000 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series B) 20-Jun-2018 0000 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 15-Jan-2016 $10M $15M 0000 Completed Pre-Clinical Trials
1. Seed Round 14-Jul-2014 $5M $5M Completed Pre-Clinical Trials
To view Kechow Pharma’s complete valuation and funding history, request access »

Kechow Pharma Patents

Kechow Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220259164-A1 Use of aminothiol compounds as cerebral nerve or heart protective agent Pending 13-Jun-2019 0000000000
EP-3984993-A1 Use of aminothiol compounds as cerebral nerve or heart protective agent Pending 13-Jun-2019 0000000000
AU-2020293522-A1 Use of aminothiol compounds as cerebral nerve or heart protective agent Pending 13-Jun-2019 0000000000
CA-3142963-A1 Use of aminothiol compounds as cerebral nerve or heart protective agent Pending 13-Jun-2019 0000000000
AU-2017318087-B2 Amino mercaptan compound and preparation method therefor and use thereof in protection against radiation Active 05-Sep-2016 A61P39/02
To view Kechow Pharma’s complete patent history, request access »

Kechow Pharma Executive Team (2)

Name Title Board Seat Contact Info
Hongqi Tian Founder, Chairman & Chief Executive Officer
Yi Liu Chief Medical Officer
To view Kechow Pharma’s complete executive team members history, request access »

Kechow Pharma Board Members (2)

Name Representing Role Since
Hongqi Tian Kechow Pharma Founder, Chairman & Chief Executive Officer 000 0000
Jacky Chen YuanBio Venture Capital Board Member 000 0000
To view Kechow Pharma’s complete board members history, request access »

Kechow Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kechow Pharma Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Suzhou Trust Venture Capital Minority 000 0000 000000 0
M31 Capital (China) PE/Buyout Minority 000 0000 000000 0
Shenzhen Capital Group Venture Capital Minority 000 0000 000000 0
Decheng Capital Venture Capital Minority 000 0000 000000 0
Qiming Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »